By Mary J. Laughlin, Hillard M. Lazarus

Across the world well-known physicians and researchers evaluation either the fundamentals of allogeneic stem telephone transplantation and up to date advances within the box, really as they relate to antitumor results and graft-versus-host affliction in addition they offer detailed decision-tree analyses to lead clinicians in picking out and dealing with their allogeneic transplant sufferers. The ideas mentioned disguise numerous components, starting from stem cellphone mobilization in general donors, to symptoms for allogeneic transplantation except hematologic malignancies, to using nonmyeloablative conditioning regimens. The authors additionally discover new advancements within the optimum number of unrelated allogeneic grafts (e.g., matched unrelated donor, partly mismatched loved one, or umbilical twine blood), the use allogeneic peripheral blood stem telephone vs marrow-derived grafts for transplantation, and the kinetics of immune reconstitution after transplantation.

Show description

Read or Download Allogeneic Stem Cell Transplantation (1st Edition) PDF

Best nonfiction_5 books

Lifelong Learning in Paid and Unpaid Work: Survey and Case Study Findings

Lifelong studying is key to all members and lately has develop into a tenet for coverage tasks, starting from nationwide financial pageant to problems with social unity and private fulfilment. notwithstanding, regardless of the significance of lifelong studying there's a severe absence of direct, foreign facts on its quantity, content material and results.

Extra resources for Allogeneic Stem Cell Transplantation (1st Edition)

Example text

Lancet 1998;351:700–708. 20. Zittoun RA, Mandelli F, Willemze R, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 1995;332:217–223. 21. Cassileth PA, Harrington DP, Appelbaum FR, et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998;339:1649–1656. 22. Bensinger W, Martin P, Storer B, et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic malignancies.

In this ongoing, prospective, randomized study, 43 Ph+ patients were treated with chemotherapy only. 002). The EFS at 3 yr was 0% for the Ph+ group vs. 001) (35). Therefore, studies have been conducted to test the efficacy of allogeneic SCT as a consolidative treatment after achievement of first remission in these patients. In the MRC UKALL XII/ECOG E2993 study, 35 patients have undergone a matched, related allogeneic SCT and had a 38% EFS at 3 yr compared to an EFS of only 5% for those PH+ patients who received chemotherapy or autologous SCT.

Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. J Clin Oncol 1991;9:1570–1574. 67. Mehta J, Powles R, Horton C, et al. Bone marrow transplantation for primary refractory acute leukemia. Bone Marrow Transplant 1994;14:415–418. 68. Biggs JC, Horowitz MM, Gale RP, et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 1992;80:1090–1093. 69. Fung HC, O’Donnell M, Popplewell L, et al.

Download PDF sample

Rated 4.03 of 5 – based on 19 votes